Retail News

FDA approves Pfizer booster for 12- to 15-year-olds

The Wall Street Journal 01/04/2022

The U.S. Food and Drug Administration said children between 12 and 15 years of age may not be administered a booster of the Pfizer-BioNTech vaccine five months after their second shot.

MORE ON THIS STORY...

MORE RETAIL NEWS HEADLINES...

Discussions
Check out RetailWire's Engaging Online Discussions Featuring Our Exclusive Braintrust!